Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation

424 General Military Hospital · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
bone-mineral-densityosteoporosis
postmenopausal osteoporosis, osteoporosis, denosumab, zoledronic acid, bone mineral density, bone markers, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 844032
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.